Dunhui Li

680 total citations
25 papers, 441 citations indexed

About

Dunhui Li is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Dunhui Li has authored 25 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 12 papers in Neurology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Dunhui Li's work include Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (6 papers) and Genetic Neurodegenerative Diseases (5 papers). Dunhui Li is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (12 papers), Neurological disorders and treatments (6 papers) and Genetic Neurodegenerative Diseases (5 papers). Dunhui Li collaborates with scholars based in China, Australia and United States. Dunhui Li's co-authors include Steve D. Wilton, Frank Mastaglia, Sue Fletcher, Shengdi Chen, May T. Aung-Htut, Shanping He, Guanya Li, Tao Wang, Jun Liu and Qin Xiao and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Dunhui Li

25 papers receiving 435 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dunhui Li China 11 223 170 64 48 47 25 441
Zachary T. McEachin United States 10 210 0.9× 94 0.6× 58 0.9× 58 1.2× 62 1.3× 18 354
Zhi-hua Yang China 8 179 0.8× 99 0.6× 60 0.9× 63 1.3× 50 1.1× 15 324
Helen Latsoudis Greece 12 193 0.9× 122 0.7× 119 1.9× 52 1.1× 84 1.8× 27 413
Maria Guarnaccia Italy 10 154 0.7× 76 0.4× 29 0.5× 32 0.7× 42 0.9× 33 313
Diana Scholz Germany 7 231 1.0× 109 0.6× 179 2.8× 38 0.8× 83 1.8× 8 486
Qinchuan Liang China 10 144 0.6× 125 0.7× 70 1.1× 18 0.4× 16 0.3× 17 396
Anwar Norazit Malaysia 11 178 0.8× 84 0.5× 62 1.0× 20 0.4× 51 1.1× 23 401
Ilaria Musante Italy 15 229 1.0× 66 0.4× 84 1.3× 51 1.1× 76 1.6× 26 627
Teresa Botta‐Orfila Spain 10 366 1.6× 128 0.8× 106 1.7× 38 0.8× 84 1.8× 13 491
Velmarini Vasquez United States 11 304 1.4× 259 1.5× 96 1.5× 23 0.5× 73 1.6× 16 519

Countries citing papers authored by Dunhui Li

Since Specialization
Citations

This map shows the geographic impact of Dunhui Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dunhui Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dunhui Li more than expected).

Fields of papers citing papers by Dunhui Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dunhui Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dunhui Li. The network helps show where Dunhui Li may publish in the future.

Co-authorship network of co-authors of Dunhui Li

This figure shows the co-authorship network connecting the top 25 collaborators of Dunhui Li. A scholar is included among the top collaborators of Dunhui Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dunhui Li. Dunhui Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Dunhui, Wai Yan Yau, Shengdi Chen, Steve D. Wilton, & Frank Mastaglia. (2025). A personalised and comprehensive approach is required to suppress or replenish SNCA for Parkinson’s disease. npj Parkinson s Disease. 11(1). 42–42. 2 indexed citations
2.
Xue, Yanyan, Yi Yang, Lulu Yu, et al.. (2024). The effects of a psychoeducational intervention on caregivers of colorectal cancer patients: A meta-analysis of randomized controlled trials. European Journal of Oncology Nursing. 74. 102739–102739. 1 indexed citations
3.
Wang, Xiaokai, Shengjie Guo, Lulu Yu, et al.. (2024). Financial toxicity of informal caregivers of colorectal cancer patients: A cross-sectional study. European Journal of Oncology Nursing. 69. 102519–102519. 5 indexed citations
4.
Aung-Htut, May T., et al.. (2024). Antisense oligonucleotides and their applications in rare neurological diseases. Frontiers in Neuroscience. 18. 1414658–1414658. 7 indexed citations
5.
Hodgetts, Stuart I., et al.. (2024). Controversies and insights into PTBP1-related astrocyte-neuron transdifferentiation: neuronal regeneration strategies for Parkinson’s and Alzheimer’s disease. Translational Neurodegeneration. 13(1). 59–59. 3 indexed citations
6.
Li, Dunhui, Frank Mastaglia, Wai Yan Yau, et al.. (2022). Targeted Molecular Therapeutics for Parkinson's Disease: A Role for Antisense Oligonucleotides?. Movement Disorders. 37(11). 2184–2190. 4 indexed citations
7.
Al‐Salami, Hani, et al.. (2022). β-cyclodextrin Based Nano Gene Delivery Using Pharmaceutical Applications to Treat Wolfram Syndrome. Therapeutic Delivery. 13(9). 449–462. 1 indexed citations
8.
Li, Dunhui, et al.. (2021). Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies. Biomedicines. 9(11). 1499–1499. 9 indexed citations
9.
Li, Dunhui, et al.. (2021). Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies. Translational Neurodegeneration. 10(1). 16–16. 51 indexed citations
10.
Li, Dunhui, A.M. Adams, R. Johnsen, Sue Fletcher, & Steve D. Wilton. (2020). Morpholino Oligomer-Induced Dystrophin Isoforms to Map the Functional Domains in the Dystrophin Protein. Molecular Therapy — Nucleic Acids. 22. 263–272. 10 indexed citations
11.
Li, Dunhui, Frank Mastaglia, Sue Fletcher, & Steve D. Wilton. (2020). Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era. Medicinal Research Reviews. 40(6). 2650–2681. 39 indexed citations
12.
Li, Dunhui, et al.. (2020). A Splice Intervention Therapy for Autosomal Recessive Juvenile Parkinson’s Disease Arising from Parkin Mutations. International Journal of Molecular Sciences. 21(19). 7282–7282. 10 indexed citations
13.
Li, Dunhui, Frank Mastaglia, Sue Fletcher, & Steve D. Wilton. (2018). Precision Medicine through Antisense Oligonucleotide-Mediated Exon Skipping. Trends in Pharmacological Sciences. 39(11). 982–994. 58 indexed citations
14.
Qiao, Yuan, Xiang Gao, Liang Liang, et al.. (2016). A community-based study of risk factors for probable rapid eye movement sleep behavior disorder. Sleep Medicine. 30. 71–76. 32 indexed citations
15.
Gao, Chao, Yimeng Chen, Qian Sun, et al.. (2016). Mutation analysis of CHCHD2 gene in Chinese Han familial essential tremor patients and familial Parkinson's disease patients. Neurobiology of Aging. 49. 218.e9–218.e11. 8 indexed citations
16.
Zhou, Haiyan, Qian Sun, Yuyan Tan, et al.. (2016). Substantia nigra echogenicity correlated with clinical features of Parkinson's disease. Parkinsonism & Related Disorders. 24. 28–33. 29 indexed citations
17.
Li, Dunhui, et al.. (2016). Diagnostic Accuracy of Transcranial Sonography of the Substantia Nigra in Parkinson’s disease: A Systematic Review and Meta-analysis. Scientific Reports. 6(1). 20863–20863. 51 indexed citations
18.
Tan, Yuyan, Li Wu, Dunhui Li, et al.. (2016). Methylation status of DJ-1 in leukocyte DNA of Parkinson’s disease patients. Translational Neurodegeneration. 5(1). 5–5. 15 indexed citations
19.
Sun, Qian, Tian Wang, Pei Huang, et al.. (2015). Clinical features of Parkinson's disease with freezing of gait. Chin J Neurol. 48(7). 575–579. 1 indexed citations
20.
Li, Dunhui, Xufeng Jiang, Haiyan Zhou, et al.. (2015). Transcranial sonography of the substantia nigra and its correlation with DAT-SPECT in the diagnosis of Parkinson's disease. Parkinsonism & Related Disorders. 21(8). 923–928. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026